The distinct and restricted expression of 4-1BB on tumor specific T cells in the tumor environment in combination with the ability of 4-1BB signaling to reactivate T cells with an exhausted phenotype and NK cells makes 4-1BB an attractive target in immuno-oncology [6–10, 39]. The gene discussed is TNFRSF9; the disease is neoplasm.